ACQUIREDT+30
Anderson Kenneth Carl
C4 Therapeutics Inc · NASDAQ
+3,662 sh · $11.5K
Filed 2 Oct 2026SEC Form 4view source
BlackRock
13F filer
$21.0M
4,551,510 sh
Two Sigma Investments
13F filer
$8.0M
3,035,634 sh
Renaissance Technologies
13F filer
$6.5M
2,461,815 sh
Grogan Donna Roy
US insider
$14.5K
4,618 sh
Anderson Kenneth Carl
US insider
$11.5K
3,662 sh
Adams Kendra
US insider
$9.4K
3,475 sh
Anderson Kenneth Carl
C4 Therapeutics Inc · NASDAQ
+3,662 sh · $11.5K
Grogan Donna Roy
C4 Therapeutics Inc · NASDAQ
+4,618 sh · $14.5K
Adams Kendra
C4 Therapeutics Inc · NASDAQ
+6,250 sh
Adams Kendra
C4 Therapeutics Inc · NASDAQ
−2,775 sh · $9.4K
Renaissance Technologies
C4 Therapeutics Inc · NASDAQ
2,461,815 sh · $6.5M
Two Sigma Investments
C4 Therapeutics Inc · NASDAQ
3,035,634 sh · $8.0M
BlackRock
C4 Therapeutics Inc · NASDAQ
4,551,510 sh · $21.0M